Sam Heywood - Concepedia

Author

Sam Heywood

UCB Pharma (United Kingdom)

Also Known As

S. Heywood, S. P. Heywood, S.P. Heywood, SAM P HEYWOOD, SAM P. HEYWOOD, Sam Heywood, Sam P Heywood, Sam P. Heywood

Publications

459

Citations

H-Index

Concepts

All Affiliations

UCB Pharma (United Kingdom)University of Bath Ludwig Cancer Research

About

Sam Heywood is an author at UCB Pharma (United Kingdom) specializing in medicine, immunology, and antibody engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	264
2	Natural Sciences	3	3	125
3	Biochemistry	3	3	125
4	Engineering	2	2	28
5	Allergy	1	1	27

Sam Heywood

Publications

435

Citations

H-Index

Page 1

	Year	Citations
Prolonged in Vivo Residence Times of Antibody Fragments Associated with Albumin Bryan John Smith, Andrew G. Popplewell, Dee Athwal, Bioconjugate Chemistry	2001	92
Extending the half-life of a fab fragment through generation of a humanized anti-human serum albumin Fv domain: An investigation into the correlation between affinity and serum half-life Ralph Adams, Laura Griffin, Joanne Compson, mAbs Crystal StructureImmunologyMolecular BiologyImmunochemistryHalf-life Extension	2016	64
Alternative antibody Fab′ fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering David P. Humphreys, Sam Heywood, Alistair J. Henry, Protein Engineering Design and Selection Peg SizePeptide ScienceChemical BiologyMedicinal ChemistryHinge Cysteine	2007	46
Cell surface dynamics and cellular distribution of endogenous FcRn Lena E. D’Hooghe, Andrew D. Chalmers, Sam Heywood, PLoS ONE Signal TransductionSteady StateCell InteractionCell TraffickingImmunology	2017	43
Towards a universal disulphide stabilised single chain Fv format: importance of interchain disulphide bond location and vL-vH orientation Eve E. Weatherill, Katharine Cain, Sam Heywood, Protein Engineering Design and Selection	2012	42
Fab-dsFv: A bispecific antibody format with extended serum half-life through albumin binding Emma Davé, Ralph Adams, Oliver Zaccheo, mAbs Immunocytochemical TechniqueImmunologyPathologyViral Structural ProteinImmunotherapy	2016	41
PEGylation prolongs the pulmonary retention of an anti-IL-17A Fab’ antibody fragment after pulmonary delivery in three different species Danielle Freches, Harshad P. Patil, Maria Machado Franco, International Journal of Pharmaceutics AllergyLung InflammationImmunologyPulmonary DeliveryHumoral Immunity	2017	27
IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design Chloe Louisa Stoyle, Paul E. Stephens, David P. Humphreys, Biochemical Journal	2017	22
Development and Application of a Fluorometric Assay for Mammalian Membrane Dipeptidase Sam Heywood, Nigel M. Hooper Analytical Biochemistry Proteinlipid InteractionBiochemistryNatural SciencesMedicineBioanalysis	1995	15
Production, purification and biological characterization of mono-PEGylated anti-IL-17A antibody fragments Salome-Juliette Koussoroplis, Sam Heywood, Catherine Uyttenhove, International Journal of Pharmaceutics EngineeringAutoimmune DiseaseImmunoengineeringImmunologyAntibody Screening	2013	15

Page 1